BRD2 and neoplasm: Examination of sample-wise mRNA-protein correlation indicated a lower median sample-wise correlation for tumor samples (0.44) than for NAT samples (0.52), which had lower variance (Figures 3B and S3A; Benjamini-Hochberg adjusted p < 0.001).